Haemonetics Welcomes New FDA Guidance on Viscoelastic Testing During COVID-19 Pandemic
Go back to Haemonetics Welcomes New FDA Guidance on Viscoelastic Testing During COVID-19 Pandemic| HAEMONETICS CORPORATION (NYSE: HAE) | Delayed: 104.65 +14.38 (15.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $90.27 | 52 Week High | $39.41 | |||
| Open | $102.50 | 52 Week Low | $25.98 | |||
| Day High | $106.67 | P/E | 147.39 | |||
| Day Low | $102.00 | EPS | $0.71 | |||
| Volume | 2,305,285 | |||||
